Palandri, F., Ross, D. M., Cochrane, T., Tate, C., Lane, S. W., Larsen, S. R., Gerds, A. T., Halpern, A. B., Shortt, J., Rossetti, J. M., Pettit, K. M., Liang, J., Mead, A., Marchetti, M., Vannucchi, A., Wilson, A., Göthert, J. R., Hanna, M., Jones, A., Peppe, J., Natsoulis, G., McClure, T., Hong, W., Stevenson, W. S., Harrison, C. N., Talpaz, M., Vianelli, N., & Rienhoff, H. Y. (n.d.). p1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET). HemaSphere, 6, 923–924. http://access.bl.uk/ark:/81055/vdc_100159755941.0x00000b